This inventor holds 1 USPTO granted patent. Top assignees: University of Washington, Yeda Research and Develpment & Co. Ltd. Active years: 2020.
Company Filing History:
1 out of 2,166 
1 out of 1,168 Years Active: 2020
Title: Izhack Cherny: Innovator in Phosphotriesterase Research
Introduction
Izhack Cherny is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides that can mitigate the effects of organophosphate exposure.
Latest Patents
Cherny holds a patent for "Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage." This invention features a genetically modified polypeptide that exhibits at least twice the catalytic efficiency for a V-type nerve agent compared to the standard phosphotriesterase sequence, as detailed in SEQ ID NO: 1.
Career Highlights
Throughout his career, Izhack Cherny has worked with prestigious institutions, including the University of Washington and Yeda Research and Development & Co. Ltd. His work has focused on enhancing the efficacy of treatments for organophosphate-related injuries.
Collaborations
Cherny has collaborated with notable colleagues such as Sagar D. Khare and Nidhi Aggarwal, contributing to advancements in his field through teamwork and shared expertise.
Conclusion
Izhack Cherny's innovative work in the development of phosphotriesterase polypeptides showcases his commitment to addressing critical health issues related to organophosphate exposure. His contributions continue to influence the field of biochemistry and public health.